Abstract
We aim to investigate whether structural valve deterioration (SVD) of bioprosthetic xenogenic tissue heart valves (XTHVs) is associated with increased immune cell infiltration and whether co-expression of several chemokines correlates with this increase in immune infiltrate. Explanted XTHVs from patients undergoing redo valve replacement for SVD were obtained. Immunohistochemical, microscopic, and gene expression analysis approaches were used. XTHVs (n = 37) were obtained from 32 patients (mean 67.7 years) after a mean time of 11.6 years post-implantation. Significantly increased immune cellular infiltration was observed in the explanted SVD valves for all immune cell types examined, including T cells, macrophages, B cells, neutrophils, and plasma cells, compared to non-SVD controls. Furthermore, a significantly increased chemokine gradient in explanted SVD valves accompanied immune cell infiltration. These data suggest the development of SVD is associated with a significantly increased burden of immune cellular infiltrate correlated to the induction of a chemokine gradient around the XHTV, representing chronic immune rejection.
Graphical abstract
Similar content being viewed by others
Abbreviations
- FFPE:
-
Formalin-fixed, paraffin-embedded
- H&E:
-
Hematoxylin and eosin
- HPF:
-
High-powered field
- RNA:
-
Ribonucleic acid
- SVD:
-
Structural valve deterioration
- VHD:
-
Valvular heart disease
- XTHV:
-
Xenogenic tissue heart valve
References
Iung, B., & Vahanian, A. (2011). Epidemiology of valvular heart disease in the adult. Nature Reviews. Cardiology, 8, 162–172.
Iung, B., Baron, G., Butchart, E. G., et al. (2003). A prospective survey of patients with valvular heart disease in europe: the Euro Heart Survey on Valvular Heart Disease. European Heart Journal, 24, 1231–1243.
Kaneko T, Aranki S, Javed Q, et al. Mechanical versus bioprosthetic mitral valve replacement in patients <65 years old. Journal of Thoracic and Cardiovascular Surgery, 147, 117–126.
Johnston, D. R., Soltesz, E. G., Vakil, N., et al. (2015). Long-term durability of bioprosthetic aortic valves: implications from 12,569 implants. The Annals of Thoracic Surgery, 99, 1239–1247.
Dvir, D., Bourguignon, T., Otto, C. M., et al. (2018). Standardized definition of structural valve degeneration for surgical and transcatheter bioprosthetic aortic valves. Circulation, 137, 388–399.
Manji, R. A., Hara, H., & Cooper, D. K. C. (2015). Characterization of the cellular infiltrate in bioprosthetic heart valves explanted from patients with structural valve deterioration. Xenotransplantation, 22, 406–407.
Manji, R. A., Lee, W., & Cooper, D. K. C. (2015). Xenograft bioprosthetic heart valves: past, present and future. International Journal of Surgery, 23, 280–284.
O’Keefe, K. L., Cohle, S. D., McNamara, J. E., & Hooker, R. L. (2011). Early catastrophic stentless valve failure secondary to possible immune reaction. The Annals of Thoracic Surgery, 91, 1269–1272.
Dignan, R., O’Brien, M., Hogan, P., et al. (2003). Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens. The Journal of Heart Valve Disease, 12, 382–391.
Human, P., & Zilla, P. (2001). Inflammatory and immune processes: the neglected villain of bioprosthetic degeneration? Journal of Long-Term Effects of Medical Implants, 11, 199–220.
Chen, R. H., Kadner, A., Mitchell, R. N., & Adams, D. H. (2000). Fresh porcine cardiac valves are not rejected in primates. The Journal of Thoracic and Cardiovascular Surgery, 119, 1216–1220.
Böer, U., Buettner, F. F. R., Schridde, A., et al. (2017). Antibody formation towards porcine tissue in patients implanted with crosslinked heart valves is directed to antigenic tissue proteins and αGal epitopes and is reduced in healthy vegetarian subjects. Xenotransplantation, 24, e12288.
Bromley, S. K., Peterson, D. A., Gunn, M. D., & Dustin, M. L. (2000). Cutting edge: hierarchy of chemokine receptor and TCR signals regulating T cell migration and proliferation. Journal of Immunology, 165, 15–19.
Siddiqui, I., Erreni, M., van Brakel, M., Debets, R., & Allavena, P. (2016). Enhanced recruitment of genetically modified CX3CR1-positive human T cells into fractalkine/CX3CL1 expressing tumors: importance of the chemokine gradient. Journal for Immunotherapy of Cancer, 4, 21.
Nagarsheth, N., Wicha, M. S., & Zou, W. (2017). Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy. Nature Reviews. Immunology, 17, 559–572.
Adam, B. A., Smith, R. N., Rosales, I. A., et al. (2017). Chronic antibody-mediated rejection in nonhuman primate renal allografts: validation of human histological and molecular phenotypes. American Journal of Transplantation, 17, 2841–2850.
Adam, B., Afzali, B., Dominy, K. M., et al. (2016). Multiplexed color-coded probe-based gene expression assessment for clinical molecular diagnostics in formalin-fixed paraffin-embedded human renal allograft tissue. Clinical Transplantation, 30, 295–305.
Butany, J., Leong, S. W., Cunningham, K. S., D’Cruz, G., Carmichael, K., & Yau, T. M. (2007). A 10-year comparison of explanted Hancock-II and Carpentier-Edwards supraannular bioprostheses. Cardiovascular Pathology, 16, 4–13.
Sellers, S. L., Turner, C. T., Sathananthan, J., et al. (2018). Transcatheter aortic heart valves: histological analysis providing insight to leaflet thickening and structural valve degeneration. JACC: Cardiovascular Imaging, 12, 135–145.
Shetty, R., Pibarot, P., Audet, A., et al. (2009). Lipid-mediated inflammation and degeneration of bioprosthetic heart valves. European Journal of Clinical Investigation, 39, 471–480.
Palomino, D. C. T., & Marti, L. C. (2015). Chemokines and immunity. Einstein (Sao Paulo), 13, 469–473.
Bozso, S. J., Kang, J. J. H., Al-Adra, D., et al. (2019). Outcomes following bioprosthetic valve replacement in prior non-cardiac transplant recipients. Clinical Transplantation, 33, e13720.
Lund, O., Nielsen, S. L., Arildsen, H., Ilkjaer, L. B., & Pilegaard, H. K. (2000). Standard aortic St. Jude valve at 18 years: performance profile and determinants of outcome. The Annals of Thoracic Surgery, 69, 1459–1465.
Grunkemeier, G. L., Furnary, A. P., Wu, Y., Wang, L., & Starr, A. (2012). Durability of pericardial versus porcine bioprosthetic heart valves. The Journal of Thoracic and Cardiovascular Surgery, 144, 1381–1386.
Nalluri, N., Atti, V., Munir, A. B., et al. (2018). Valve in valve transcatheter aortic valve implantation (ViV-TAVI) versus redo-surgical aortic valve replacement (redo-SAVR): a systematic review and meta-analysis. Journal of Interventional Cardiology, 31, 661–671.
Kühne, L., Jung, B., Poth, H., et al. (2017). Renal allograft rejection, lymphocyte infiltration, and de novo donor-specific antibodies in a novel model of non-adherence to immunosuppressive therapy. BMC Immunology, 18, 52.
Girlanda, R., Kleiner, D. E., Duan, Z., et al. (2008). Monocyte infiltration and kidney allograft dysfunction during acute rejection. American Journal of Transplantation, 8, 600.
Veinot, J. P., Prichett-Pejic, W., Song, J., et al. (2006). CD117-positive cells and mast cells in adult human cardiac valves--observations and implications for the creation of bioengineered grafts. Cardiovascular Pathology, 15, 36–40.
Kim, W. G., Sung, K., & Seo, J. W. (2007). Time-related histopathologic analyses of immunologically untreated porcine valved conduits implanted in a porcine-to-goat model. Artificial Organs, 31, 105–113.
Ozkan, S., Akay, T. H., Gultekin, B., Sezgin, A., Tokel, K., & Aslamaci, S. (2007). Xenograft transplantation in congenital cardiac surgery at baskent university: midterm results. Transplantation Proceedings, 39, 1250–1254.
Wood, K. J., & Goto, R. (2012). Mechanisms of rejection: current perspectives. Transplantation, 93, 1–10.
Nguyen, D. C., Joyner, C. J., Sanz, I., & Lee, F. E. (2019). Factors affecting early antibody secreting cell maturation into long-lived plasma cells. Frontiers in Immunology, 10, 2138.
Naso, F., Gandaglia, A., Iop, L., Spina, M., & Gerosa, G. (2012). Alpha-gal detectors in xenotransplantation research: a word of caution. Xenotransplantation, 19, 215–220.
Galili, U. (2001). The α-gal epitope (Galα1-3Galβ1-4GlcNAc-R) in xenotransplantation. Biochimie, 83, 557–563.
McMorrow, I. M., Comrack, C. A., Sachs, D. H., & DerSimonian, H. (1997). Heterogeneity of human anti-pig natural antibodies cross-reactive with the gal (alpha1,3) galactose epitope. Transplantation, 64, 501–510.
Funding
University Hospital Foundation, Edmonton, AB
Edmonton Civic Employees Charitable Assistance Fund, Edmonton, AB
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interests
The authors declare that they have no conflicts of interest.
Statement of Informed Consent
Patient and procedural data were collected from retrospective chart reviews. The Research Ethics Board at the University of Alberta approved the research protocol, including a waiver of individual consent.
Additional information
Associate Editor Adrian Chester oversaw the review of this article
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Bozso, S.J., Kang, J.J., Basu, R. et al. Structural Valve Deterioration Is Linked to Increased Immune Infiltrate and Chemokine Expression. J. of Cardiovasc. Trans. Res. 14, 503–512 (2021). https://doi.org/10.1007/s12265-020-10080-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12265-020-10080-x